Together, these studies establish a direct link between RyR2 complex hyperactivity, RyR2 oxidation, and excessive mitochondrial-mediated ROS production, a common phenomenon in both hereditary CPVT and acquired cardiac diseases. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.